{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "STU", "shortName": "XSpray Pharma AB", "longName": "Xspray Pharma AB (publ)", "messageBoardId": "finmb_431288123", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -2.1791804, "regularMarketPrice": 4.04, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.42613637, "fiftyTwoWeekLow": 3.78, "fiftyTwoWeekHigh": 7.04, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.55, "sharesOutstanding": 22680400, "bookValue": 1.856, "fiftyDayAverage": 5.767, "fiftyDayAverageChange": -1.7270002, "fiftyDayAverageChangePercent": -0.2994625, "twoHundredDayAverage": 5.286125, "twoHundredDayAverageChange": -1.2461252, "twoHundredDayAverageChangePercent": -0.23573509, "marketCap": 95596496, "priceToBook": 2.1767242, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.09000015, "regularMarketTime": 1683890761, "regularMarketDayHigh": 4.1, "regularMarketDayRange": "4.04 - 4.1", "regularMarketDayLow": 4.04, "regularMarketVolume": 0, "regularMarketPreviousClose": 4.13, "bid": 4.05, "ask": 4.29, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stuttgart", "financialCurrency": "SEK", "regularMarketOpen": 4.1, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.26, "fiftyTwoWeekLowChangePercent": 0.06878307, "fiftyTwoWeekRange": "3.78 - 7.04", "fiftyTwoWeekHighChange": -3.0, "firstTradeDateMilliseconds": 1526018400000, "symbol": "6XP.SG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "R\u00e5sundav\u00e4gen 12", "city": "Solna", "zip": "169 67", "country": "Sweden", "phone": "46 87 30 37 00", "website": "https://www.xspraypharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include XS003 for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and XS004 for the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. The company was formerly known as Xspray Microparticles AB and changed its name to Xspray Pharma AB (publ) in 2017. Xspray Pharma AB (publ) was incorporated in 2003 and is headquartered in Solna, Sweden.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Dr. Per  Andersson Ph.D.", "age": 55, "title": "Chief Exec. Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mustafa  Demirb\u00fcker Ph.D.", "title": "Co-Founder and Science Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kerstin  Hasselgren", "age": 61, "title": "Chief Fin. Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. G\u00e9rald  Jesson", "title": "VP of Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anna-Karin  Ekberg", "age": 56, "title": "Sr. VP and Global Head of Marketing & Sales", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Charlotta  Liljebris", "age": 58, "title": "Sr. VP of R&D", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Andreas  Konar", "age": 73, "title": "Sr. VP of Bus. Devel.", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Thomas  Walz", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}